Cachet Pharmaceutical Co., Ltd.

SZSE:002462 Stock Report

Market Cap: CN¥3.3b

Cachet Pharmaceutical Future Growth

Future criteria checks 0/6

Cachet Pharmaceutical is forecast to grow revenue at 0.2% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth22.1%
Revenue growth rate0.2%
Future return on equityn/a
Analyst coverage

Low

Last updated06 Mar 2024

Recent future growth updates

No updates

Recent updates

Cachet Pharmaceutical's (SZSE:002462) Soft Earnings Are Actually Better Than They Appear

May 05
Cachet Pharmaceutical's (SZSE:002462) Soft Earnings Are Actually Better Than They Appear

Earnings and Revenue Growth Forecasts

SZSE:002462 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202530,642N/AN/AN/A1
12/31/202429,183N/AN/AN/A1
3/31/202430,6832589711,169N/A
12/31/202329,9962501,3961,595N/A
9/30/202327,7272871,2291,416N/A
6/30/202328,3912831,6591,845N/A
3/31/202326,5152861,0331,220N/A
1/1/202326,220297-352-163N/A
9/30/202226,555335-2427N/A
6/30/202225,770348-575-324N/A
3/31/202226,276351-23316N/A
12/31/202125,626354666913N/A
9/30/202126,318338699958N/A
6/30/202126,106357656918N/A
3/31/202125,0183481,2741,531N/A
12/31/202023,2563188571,115N/A
9/30/202022,670325183260N/A
6/30/202021,660300256469N/A
3/31/202021,396328-123143N/A
12/31/201922,18737631293N/A
9/30/201920,601363302510N/A
6/30/201919,67935462129N/A
3/31/201919,011339173193N/A
12/31/201817,960328-313-292N/A
9/30/201817,181323-1,151-1,127N/A
6/30/201816,223306-431-406N/A
3/31/201814,997280-728-705N/A
12/31/201714,239264N/A-374N/A
9/30/201713,270253N/A478N/A
6/30/201712,395250N/A-105N/A
3/31/201711,578240N/A197N/A
12/31/201610,972223N/A116N/A
9/30/201610,320211N/A131N/A
6/30/20169,628199N/A-171N/A
3/31/20168,922189N/A-639N/A
12/31/20158,200173N/A-310N/A
9/30/20157,540166N/A-872N/A
6/30/20156,871158N/A-839N/A
3/31/20156,188142N/A-673N/A
12/31/20145,572228N/A-764N/A
9/30/20144,976243N/A-675N/A
6/30/20144,342231N/A-413N/A
3/31/20143,907236N/A-353N/A
12/31/20133,544130N/A-312N/A
9/30/20133,12489N/A59N/A
6/30/20132,92685N/A-57N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 002462's forecast earnings growth is above the savings rate (2.9%).

Earnings vs Market: Insufficient data to determine if 002462's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 002462's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 002462's revenue (0.2% per year) is forecast to grow slower than the CN market (13.9% per year).

High Growth Revenue: 002462's revenue (0.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 002462's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.